Search

everythinglearnresearchcommunity

for

Search:↓

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

The study concluded that a new method can effectively assess scalp sun damage in balding men, which increases with age and sun exposure.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Higher IL-17A levels indicate more severe alopecia areata.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Alopecia areata affects quality of life more in adolescents than adults.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Hair loss may indicate higher risk of heart disease.

Higher antigliadin antibody levels are linked to alopecia areata severity.

More severe alopecia areata can lower quality of life.

Lower BDNF levels link to worse depression in alopecia areata patients.

Hair loss doesn't affect COVID-19 severity.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

miR-155-5p can help diagnose and track alopecia areata severity.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.